|
|
||||||||
Alters the Response of Borrelia burgdorferi-Activated Endothelium to Favor Chronic Inflammation1


,
,
,
* Graduate Program in Genetics,
Center for Infectious Diseases,
Department of Molecular Genetics and Microbiology, and
Department of Pathology, School of Medicine, Stony Brook University, Stony Brook, NY 11794
Borrelia burgdorferi, the agent of Lyme disease, promotes proinflammatory changes in the endothelium that lead to the recruitment of leukocytes. The host immune response to infection results in increased levels of IFN-
in the serum and lesions of Lyme disease patients that correlate with greater severity of disease. Therefore, the effect of IFN-
on the gene expression profile of primary human endothelial cells exposed to B. burgdorferi was determined. B. burgdorferi and IFN-
synergistically augmented the expression of 34 genes, 7 of which encode chemokines. Six of these (CCL7, CCL8, CX3CL1, CXCL9, CXCL10, and CXCL11) attract T lymphocytes, and one (CXCL2) is specific for neutrophils. Synergistic production of the attractants for T cells was confirmed at the protein level. IL-1
, TNF-
, and LPS also cooperated with IFN-
to induce synergistic production of CXCL10 by the endothelium, indicating that IFN-
potentiates inflammation in concert with a variety of mediators. An in vitro model of the blood vessel wall revealed that an increased number of human T lymphocytes traversed the endothelium exposed to B. burgdorferi and IFN-
, as compared with unstimulated endothelial monolayers. In contrast, addition of IFN-
diminished the migration of neutrophils across the B. burgdorferi-activated endothelium. IFN-
thus alters gene expression by endothelia exposed to B. burgdorferi in a manner that promotes recruitment of T cells and suppresses that of neutrophils. This modulation may facilitate the development of chronic inflammatory lesions in Lyme disease.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by National Institutes of Health Grants AI47313 and AI055621.
2 Address correspondence and reprint requests to Dr. Martha B. Furie, Center for Infectious Diseases, Stony Brook University, Room 240 CMM, Stony Brook, NY 11794-5120. E-mail address: Martha.Furie{at}stonybrook.edu
3 Abbreviations used in this paper: LD, Lyme disease; sp/EC, spirochetes per endothelial cell.
4 The online version of this article contains supplemental material.
This article has been cited by other articles:
![]() |
M. M. Petzke, A. Brooks, M. A. Krupna, D. Mordue, and I. Schwartz Recognition of Borrelia burgdorferi, the Lyme Disease Spirochete, by TLR7 and TLR9 Induces a Type I IFN Response by Human Immune Cells J. Immunol., October 15, 2009; 183(8): 5279 - 5292. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Bende, F. van Maldegem, and C. J.M. van Noesel Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas Haematologica, August 1, 2009; 94(8): 1109 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Nardelli, S. M. Callister, and R. F. Schell Lyme Arthritis: Current Concepts and a Change in Paradigm Clin. Vaccine Immunol., January 1, 2008; 15(1): 21 - 34. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |